Cheng‐Yu Yang

580 total citations
33 papers, 433 citations indexed

About

Cheng‐Yu Yang is a scholar working on Molecular Biology, Pharmacology and Pathology and Forensic Medicine. According to data from OpenAlex, Cheng‐Yu Yang has authored 33 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Pharmacology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Cheng‐Yu Yang's work include Inflammatory mediators and NSAID effects (4 papers), Cancer Mechanisms and Therapy (3 papers) and Natural Compounds in Disease Treatment (3 papers). Cheng‐Yu Yang is often cited by papers focused on Inflammatory mediators and NSAID effects (4 papers), Cancer Mechanisms and Therapy (3 papers) and Natural Compounds in Disease Treatment (3 papers). Cheng‐Yu Yang collaborates with scholars based in Taiwan, China and Australia. Cheng‐Yu Yang's co-authors include Ching‐Liang Meng, Chih‐Kung Lin, Yuan‐Wu Chen, Huey‐Kang Sytwu, Gu‐Jiun Lin, Wei‐Chin Chang, Chun‐Shu Lin, Cheng‐Chih Hsieh, Yu‐Hsuan Li and Kuo‐Hsing Ma and has published in prestigious journals such as PLoS ONE, Frontiers in Microbiology and Journal of Dental Research.

In The Last Decade

Cheng‐Yu Yang

30 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng‐Yu Yang Taiwan 12 172 92 77 56 51 33 433
Niels Aarsæther Norway 14 539 3.1× 70 0.8× 8 0.1× 79 1.4× 45 0.9× 24 747
Mariana Bisarro dos Reis Brazil 14 280 1.6× 116 1.3× 13 0.2× 154 2.8× 25 0.5× 35 502
Maria Louka Greece 11 216 1.3× 60 0.7× 5 0.1× 90 1.6× 21 0.4× 17 451
Yinglu Guo China 9 162 0.9× 38 0.4× 14 0.2× 50 0.9× 67 1.3× 29 396
Xiaoxia Yang China 11 117 0.7× 43 0.5× 9 0.1× 26 0.5× 26 0.5× 26 301
André van Helvoort Lengert Brazil 14 262 1.5× 54 0.6× 3 0.0× 96 1.7× 91 1.8× 29 513
Seiji Yoshizawa Japan 10 116 0.7× 30 0.3× 3 0.0× 17 0.3× 17 0.3× 26 503
Ala F. Nassar United States 9 177 1.0× 80 0.9× 3 0.0× 22 0.4× 14 0.3× 20 428
Xiaoming Qiu China 14 712 4.1× 127 1.4× 8 0.1× 132 2.4× 84 1.6× 53 1.2k

Countries citing papers authored by Cheng‐Yu Yang

Since Specialization
Citations

This map shows the geographic impact of Cheng‐Yu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Yu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Yu Yang more than expected).

Fields of papers citing papers by Cheng‐Yu Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Yu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Yu Yang. The network helps show where Cheng‐Yu Yang may publish in the future.

Co-authorship network of co-authors of Cheng‐Yu Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Yu Yang. A scholar is included among the top collaborators of Cheng‐Yu Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Yu Yang. Cheng‐Yu Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Cheng‐Yu, et al.. (2025). Exploring the effect and mechanism of fucoidan on liver cancer depending on network pharmacology and experimental verification. Frontiers in Chemistry. 13. 1638785–1638785. 1 indexed citations
2.
3.
Yi, Dan, Cheng‐Yu Yang, Sibin Wang, et al.. (2024). Establishment and verification of a nomogram that predicts the risk for coronary slow flow. Frontiers in Endocrinology. 15. 1337284–1337284.
4.
Yang, Cheng‐Yu, et al.. (2024). The effects of pterygomaxillary disjunction in surgically assisted rapid maxillary expansion: A systematic review and meta‐analysis. Orthodontics and Craniofacial Research. 27(5). 750–757. 2 indexed citations
5.
Chia, Wei‐Tso, Cheng‐Yu Yang, Cheng‐Chih Hsieh, et al.. (2024). Okanin Inhibits Cell Growth and Induces Apoptosis and Pyroptosis in Oral Cancer. Cancers. 16(18). 3195–3195. 2 indexed citations
6.
Yi, Dan, et al.. (2023). Major Adverse Cardiovascular Events and Prognosis in Patients With Coronary Slow Flow. Current Problems in Cardiology. 49(1). 102074–102074. 5 indexed citations
7.
Liu, Wenjun, et al.. (2023). M6A Promotes Colorectal Cancer Progression via Regulating the miR-27a-3p/BTG2 Pathway. Journal of Oncology. 2023. 1–11. 4 indexed citations
8.
9.
Yang, Cheng‐Yu, Chang‐Huei Tsao, Cheng‐Chih Hsieh, et al.. (2020). Downregulation of Jumonji-C domain-containing protein 5 inhibits proliferation by silibinin in the oral cancer PDTX model. PLoS ONE. 15(7). e0236101–e0236101. 15 indexed citations
10.
Chang, Wei‐Chin, et al.. (2019). Comparison of the hospitalization period after microvascularreconstruction flap in trismus patients: free anterolateral thigh flap versus freeforearm flap. Clinical Oral Investigations. 23(7). 2951–2957. 4 indexed citations
11.
Chang, Wei‐Chin, Cheng‐Yu Yang, Chun‐Shu Lin, Chih‐Kung Lin, & Yuan‐Wu Chen. (2019). Pretreatment body mass index as a prognostic predictor in patients with oral squamous cell carcinoma. Clinical Oral Investigations. 24(8). 2781–2788. 13 indexed citations
12.
Chang, Wei‐Chin, et al.. (2019). A histopathological evaluation and potential prognostic implications of oral squamous cell carcinoma with adverse features. Oral Oncology. 95. 65–73. 40 indexed citations
13.
Yang, Cheng‐Yu, Cheng‐Chih Hsieh, Chih‐Kung Lin, et al.. (2017). Danshen extract circumvents drug resistance and represses cell growth in human oral cancer cells. BMC Complementary and Alternative Medicine. 17(1). 555–555. 16 indexed citations
14.
Chang, Wei‐Chin, Chun‐Shu Lin, Cheng‐Yu Yang, Chih‐Kung Lin, & Yuan‐Wu Chen. (2017). Lymph node density as a prognostic predictor in patients with betel nut-related oral squamous cell carcinoma. Clinical Oral Investigations. 22(3). 1513–1521. 22 indexed citations
15.
Yang, Cheng‐Yu, Chih‐Kung Lin, Gu‐Jiun Lin, et al.. (2016). Triptolide represses oral cancer cell proliferation, invasion, migration, and angiogenesis in co-inoculation with U937 cells. Clinical Oral Investigations. 21(1). 419–427. 22 indexed citations
16.
Chiang, Pei‐Wen, D. Yu. Rogozin, Yu-Ting Wu, et al.. (2016). Bacterial Communities of Three Saline Meromictic Lakes in Central Asia. PLoS ONE. 11(3). e0150847–e0150847. 43 indexed citations
17.
Hsieh, Yun-Jung, Chia‐Ling Chen, Cheng‐Yu Yang, et al.. (2015). Anticancer efficacy of unique pyridine-based tetraindoles. European Journal of Medicinal Chemistry. 104. 165–176. 17 indexed citations
18.
Yang, Cheng‐Yu, et al.. (2003). Regulation of cell growth by selective COX-2 inhibitors in oral carcinoma cell lines. Prostaglandins & Other Lipid Mediators. 72(3-4). 115–130. 19 indexed citations
19.
Yang, Cheng‐Yu, et al.. (2002). The effect of betel nut extract on cell growth and prostaglandin endoperoxide synthase in human epidermoid carcinoma cells. Prostaglandins & Other Lipid Mediators. 67(3-4). 181–195. 4 indexed citations
20.
Meng, Ching‐Liang, et al.. (1998). Inhibition of the synthesis of eicosanoid-like substances in a human oral cancer cell line by interferon-γ and eicosapentaenoic Acid. Archives of Oral Biology. 43(12). 979–986. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Niels Aarsæther Breakdown of academic impact, for papers by Mariana Bisarro dos Reis Breakdown of academic impact, for papers by Maria Louka Breakdown of academic impact, for papers by Yinglu Guo Breakdown of academic impact, for papers by Xiaoxia Yang Breakdown of academic impact, for papers by André van Helvoort Lengert Breakdown of academic impact, for papers by Seiji Yoshizawa Breakdown of academic impact, for papers by Ala F. Nassar Breakdown of academic impact, for papers by Xiaoming Qiu
Rankless by CCL
2026